Navigation Links
CVS Caremark Reports Record Results in Fourth Quarter and Fiscal 2009
Date:2/8/2010

g is a reconciliation of the Company's business segments to the accompanying consolidated financial statements:

    
    
    
                                                                
                  Pharmacy    Retail                   
                  Services   Pharmacy               Intersegment
                  Segment    Segment   Corporate    Eliminations  Consolidated
    In millions    (2)(4)      (4)      Segment        (3)(4)        Totals
    -----------   --------   --------  ---------   -------------  ------------
                                                                   
    Fourth Quarter
     Ended(1):
     December 31, 
      2009:                                            
      Net revenues $13,492    $14,455     $--         $(2,125)      $25,822
      Gross profit   1,075      4,511      --             (18)        5,568
      Operating 
       profit (loss)   833      1,220    (140)            (18)        1,895
     December 31, 
      2008(5):                                                         
      Net revenues $11,784    $13,832     $--         $(1,474)      $24,142
      Gross profit   1,020      4,204      --              --         5,224
      Operating 
       profit (loss)   809      1,051    (128)             --         1,732
    
    Fiscal Year
     Ended(1):
     December 31, 
      2009:                                            
      Net revenues $51,065    $55,355     $--         $(7,691)      $98,729
      Gross profit   3,835     16,593      --             (48)       20,380
      Operating 
       profit (loss) 2,866      4,159    (539)            (48)        6,438
     December 31, 
      2008(5):                                                         
      Net revenues $43,769    $48,990     $--         $(5,287)      $87,472
      Gross profit   3,550     14,741      --              (1)       18,290
      Operating 
       profit (loss) 2,755      3,753    (461)             (1)        
'/>"/>
SOURCE CVS Caremark Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine news :

1. CVS Caremark to Provide $3 Million in Free Flu Shots to the Unemployed
2. CVS Caremark Data Finds More than 50 Percent of Adults 45-years and Younger are not Adherent to Cholesterol Lowering Medications
3. CVS Caremark Announces Results of 2009 Health IQ Study
4. CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients
5. CVS Caremark Names Andrew J. Sussman, M.D., as President/Chief Operating Officer of MinuteClinic
6. CVS Caremark Charitable Trust Invests $300,000 in Easter Seals' Autism Services for Young Children
7. Cardinal Health Renews Distribution Agreement With CVS Caremark
8. ARTHUR(R) and CVS Caremark Debut the Winner of the ARTHUR/All Kids Can Character Search June 30 on PBS KIDS GO!(SM)
9. CVS Caremark Recognized with Gold Award from National Business Group on Health for Promoting Healthy Lifestyles for Employees
10. CVS Caremark Ranks Among 50 Best Fertility- and Adoption-Friendly Workplaces in America
11. Video: CVS Caremark Charitable Trust Awards $4.2 Million in Grants Benefiting Children with Disabilities, Uninsured
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... , ... On Saturday, July 11, 2015, during the annual New York State ... was proud to recognize Dr. Merritt F. Spear as the 2015 recipient of the ... long-time NYSATA member and Ithaca College athletic trainer and educator, is considered for individuals ...
(Date:8/31/2015)... ... ... Adult & Pediatric Dermatology in Greenwood Village, CO has launched a new ... services available to help them. , The website better showcases the practice to ... to view the website seamlessly on any desktop computer, tablet or mobile device. , ...
(Date:8/31/2015)... ... ... The Marietta dentists and staff at Verde Pointe Dental Associates ... staff ran a 5K race, the Iron Horse for Enduring Hearts on August 30th, ... the event to help support projects with funding to increase understanding of clinical and ...
(Date:8/30/2015)... ... 31, 2015 , ... Negotiating an FDA Import Hold Crisis:, Strategies for Challenging ... http://www.fdanews.com/importholdcrisis , US authorities are holding imports more than ever before, particularly ... With alerts on an uptick and a new final rule, having a top-notch import ...
(Date:8/30/2015)... (PRWEB) , ... August 30, 2015 , ... ... across platforms and devices, today announced it is a Silver Sponsor of the ... at Sky City Convention Centre in Auckland, NZ. Throughout the event, AvePoint will ...
Breaking Medicine News(10 mins):Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 2Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 3Health News:Adult & Pediatric Dermatology Launches Responsive Design Website 2Health News:Adult & Pediatric Dermatology Launches Responsive Design Website 3Health News:Verde Pointe Dental Associates Runs a 5K for Enduring Hearts 2Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 2Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 2Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 4
... test is all it could take to tell if you ... team of international scientists have discovered more than 10 types ... of a person who recently suffered a stroke or heart ... international collaboration led by Nanyang Technological University (NTU),s lead scientist, ...
... Virginia G. Piper Cancer Center Clinical Trials are the first ... determine the safety, tolerability and preliminary activity of an investigational ... form of lung cancer, as well as other forms of ... patient on the study was administered the first dose of ...
... in infant death are significantly more likely to have ... September) in BJOG: An International Journal of Obstetrics ... rates of stillbirth in subsequent pregnancy, the study by ... the University of Rochester found. Infant mortality ...
... News) -- People who are depressed are at greater risk ... researchers pointed out that the findings could have a significant ... of death and permanent disability. Researchers analyzed 28 previous ... 8,478 stroke cases. The investigators found that depression was associated ...
... Scientists proposing to develop vaccines against methamphetamine and nicotine ... for Innovative Medication Development Research. The two scientists, ... and Dr. Peter Burkhard, of the University of Connecticut, ... years to support their research, according to the National ...
... , TUESDAY, Sept. 20 (HealthDay News) -- Black women who develop ... second cancer in the other breast, and those who are diagnosed ... cancer of a more aggressive form, new research indicates. ... to be more aggressive, more likely to be estrogen-receptor negative and ...
Cached Medicine News:Health News:Novel research set to pinpoint risk of heart attacks and strokes 2Health News:Novel research set to pinpoint risk of heart attacks and strokes 3Health News:TGen-Virginia G. Piper Cancer Center launches clinical trial for drug to treat lung cancer 2Health News:Infant mortality linked to subsequent risk of stillbirth finds new US study 2Health News:Infant mortality linked to subsequent risk of stillbirth finds new US study 3Health News:Depression Tied to Higher Risk for Stroke 2Health News:NIDA Avant-Garde-Medications Development Award winners announced 2Health News:Higher Risk of Second Breast Cancer Seen in Black Women 2
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on ... their offering. Developed by Novo Nordisk, ... is an important drug for the treatment of ... a fast- acting insulin analog, starts working fast ...
(Date:8/28/2015)... Aug. 28, 2015 Perrigo Company plc ("Perrigo") ... Mylan N.V. ("Mylan") (NASDAQ: MYL ) shareholder vote ... "Our views of Mylan,s offer to Perrigo shareholders ... on our Board,s careful reflection of the value available ... limited choices that Mylan has allowed its shareholders to ...
(Date:8/28/2015)... The report "Eubiotics Market by Type (Probiotics, Prebiotics, ... Aquaculture), & by Region ( North America , ... and Rest of the World) - Global Trends and Forecast ... was valued at USD 4.62 Billion in 2014 and is ... CAGR of 7.4% from 2015 to 2020. ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5
... 2007 - Cytogen,Corporation (NASDAQ: CYTO) reported updated ... evaluating QUADRAMET(R) (samarium Sm-153,lexidronam injection) in combination ... with relapsed,multiple myeloma. Data from 33 patients ... 1 Trial of Bortezomib (Vel) and Samarium,(Sam) ...
... achieved with VELCADE, lenalidomide,and dexamethasone , ,KOS, ... (Nasdaq: MLNM) today reported on the,presentation of ... based,therapies that showed consistently high survival and ... newly diagnosed,multiple myeloma (MM) patients. These data ...
Cached Medicine Technology:Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 2Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 3Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 4Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 5Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 6Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 7Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 8Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 2Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 3Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 4Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 5Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 6Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 7Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 8
For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p...
Clerz Plus helps retain moisture to relieve dryness and removes protein buildup from your lenses while you wear them for longer wear comfort....
Refresh Contacts provides moisturizing relief from dryness and irritation associated with lens wear....
Lens Plus rewetting drops for soft contact lenses....
Medicine Products: